[Comments-igo-ingo-crp-recommendations-11jul19] GNSO Policy Development Process on IGO-INGO Access to Curative Rights Protection Mechanisms Policy Recommendations for ICANN Board Consideration

Philippe Vorreux philippe.vorreux at embl.de
Mon Aug 19 08:56:45 UTC 2019

Dear Sir, Madam,

The European Molecular Biology Laboratory (EMBL) supports the comments submitted by the OECD in their entirety.

The recommendations approved by the GNSO IGO-INGO Access to Curative Rights Protection Mechanisms PDP Working Group are in contradiction with the privileges and immunities granted to IGOs by their Member States in order to protect their independence and allow them to complete their mission. IGOs should not be forced to waive their jurisdictional immunity when it comes to domain name disputes involving IGOs, which should be solved by alternative dispute resolution mechanisms. We therefore urge the Working Group to reconsider its recommendations.

Yours sincerely,

Philippe VORREUX
Head of Legal Services
European Molecular Biology Laboratory
Meyerhofstrasse 1
69117 Heidelberg
Tel. +49 6221 387 8428
Email. philippe.vorreux at embl.de<mailto:philippe.vorreux at embl.de>

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mm.icann.org/pipermail/comments-igo-ingo-crp-recommendations-11jul19/attachments/20190819/b318d069/attachment-0001.html>

More information about the Comments-igo-ingo-crp-recommendations-11jul19 mailing list